Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (21-30 of 518) with videos related to

Pageof 52
Sort By:
Blood|October 26, 2013
HIV, EBV, and monoclonal gammopathySham Mailankody, Ola Landgren
Blood|April 15, 2021
Familial patterns of hematologic precursorsOla Landgren, Francesco Maura
British Journal of Haematology|January 3, 2024
Early detection of multiple myeloma: A first step towards a screening programmeChristof Scheid, Ola Landgren
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime timeDickran Kazandjian, Ola Landgren
Seminars in Oncology|January 8, 2017
A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survivalDickran Kazandjian, Ola Landgren
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola Landgren
The New England Journal of Medicine|August 10, 2022
T-Cell Engagers - Modern Immune-Based Therapies for Multiple MyelomaSham Mailankody, Ola Landgren
Advances in Therapy|June 16, 2023
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A PodcastOla Landgren, Omar Nadeem
The New England Journal of Medicine|December 11, 2012
MYD88 L265P somatic mutation in IgM MGUSOla Landgren, Louis Staudt
Leukemia & Lymphoma|January 8, 2013
Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging "early myeloma"Jens Hillengass, Ola Landgren
Pageof 52

Showing results (21-30 of 518) with videos related to

Sort By:
Pageof 52
Blood|October 26, 2013
HIV, EBV, and monoclonal gammopathySham Mailankody, Ola Landgren
Blood|April 15, 2021
Familial patterns of hematologic precursorsOla Landgren, Francesco Maura
British Journal of Haematology|January 3, 2024
Early detection of multiple myeloma: A first step towards a screening programmeChristof Scheid, Ola Landgren
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime timeDickran Kazandjian, Ola Landgren
Seminars in Oncology|January 8, 2017
A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survivalDickran Kazandjian, Ola Landgren
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola Landgren
The New England Journal of Medicine|August 10, 2022
T-Cell Engagers - Modern Immune-Based Therapies for Multiple MyelomaSham Mailankody, Ola Landgren
Advances in Therapy|June 16, 2023
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A PodcastOla Landgren, Omar Nadeem
The New England Journal of Medicine|December 11, 2012
MYD88 L265P somatic mutation in IgM MGUSOla Landgren, Louis Staudt
Leukemia & Lymphoma|January 8, 2013
Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging "early myeloma"Jens Hillengass, Ola Landgren
Pageof 52